Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 18;10:616440. doi: 10.3389/fonc.2020.616440

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Song, Kwon, Kim, Lee, Han, Kim, Byun, Lee, Lee, Lee, Lee, Jang and Park

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Overall survival correlated to number of circulating tumor cells (CTCs) detected using epithelial cell adhesion molecule (EpCAM) and Plectin-1 in peripheral blood and portal blood. CTC counts based on EpCAM and Plectin-1 expression were evaluated with Overall survival (OS) of 32 PDAC patients. Patients were divided into two groups depending on detectable EpCAM⁺ CTCs in (A) Peripheral vein and (B) Portal vein. Patients were divided into two groups depending on detectable Plectin-1⁺ CTCs in (C) Peripheral vein and (D) Portal vein. OS was analyzed with the number of CTCs using Kaplan-Meier estimator.